GlassScriptPhysician profile
Deepti Nahar
NPI 1871818351
$9,398.45
in general payments reported to CMS, 2019-2025
30 companies · $3,373 in 2025
The $3,373 reported for 2025 was more than what 96% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2020: $286 · 2021: $1,429 · 2022: $1,296 · 2023: $1,576 · 2024: $973 · 2025: $3,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,040 · Education: $2,500 · Travel and Lodging: $358 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,040.33 |
| Education | $2,500.00 |
| Travel and Lodging | $357.93 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,688.66 | 2019-2025 | Da Vinci Surgical System |
| Abbvie INC. | $1,654.61 | 2019-2025 | |
| Coloplast Corp | $578.30 | 2019-2025 | |
| Hologic Sales and Service, LLC | $468.91 | 2021-2025 | Acessa Provu System, Novasure, Omni Hysteroscope |
| Daiichi Sankyo INC. | $457.79 | 2019-2023 | Injectafer |
| Mayne Pharma Commercial LLC | $295.26 | 2023-2025 | |
| Myovant Sciences INC. | $284.29 | 2021-2022 | |
| Shield Therapeutics INC | $278.09 | 2023-2025 | Accrufer |
| Pfizer INC. | $214.32 | 2021-2024 | |
| Aspira Women'S Health INC | $210.48 | 2021-2024 | Ova1 |
| Boston Scientific Corporation | $153.35 | 2019-2024 | Solyx Sis System |
| Cytyc Surgical Products, LLC | $144.12 | 2023 | Acessa Provu System |
| Organon LLC | $142.34 | 2022-2023 | Nexplanon |
| Astellas Pharma US INC | $115.93 | 2023-2025 | Veozah |
| Axonics, INC. | $105.29 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $97.18 | 2019-2022 | |
| Biogen, INC. | $97.13 | 2024 | Zurzuvae |
| Abbott Laboratories | $73.17 | 2024 | Proclaim |
| Amag Pharmaceuticals, INC. | $66.44 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $58.86 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $55.70 | 2023-2025 | Myfembree, Gemtesa |
| Exact Sciences Corporation | $27.76 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $23.37 | 2020 | |
| Davol INC. | $20.61 | 2024 | Arista Ah Flexitip |
| Coopersurgical, INC. | $16.99 | 2022 | |
| Ascend Therapeutics US, LLC | $16.85 | 2022 | |
| Agile Therapeutics, INC. | $16.09 | 2021 | |
| Lupin INC. | $12.43 | 2019 | |
| Avion Pharmaceuticals | $12.32 | 2022 | |
| Minerva Surgical, INC | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepti Nahar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.